News & Updates

Enzalutamide edges out abiraterone in mCRPC

15 Sep 2024 by

In the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC), the use of enzalutamide yields small improvements in outcomes when compared with abiraterone acetate, according to a retrospective study.

Enzalutamide edges out abiraterone in mCRPC

15 Sep 2024

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney

15 Sep 2024 by

For atrial fibrillation (AF) patients with normal or impaired renal function, use of nonvitamin K antagonist oral anticoagulants (NOACs) results in improved outcomes relative to vitamin K antagonist (VKA) therapy, suggests a study presented at ESC 2024.

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney

15 Sep 2024

Menopausal hormone therapy may boost beneficial bacteria in vaginal microbial community

15 Sep 2024

Postmenopausal women who use menopausal hormone therapy (MHT) appear to have increased Lactobacillus abundance and lower vaginal microbial community diversity, according to a study.

Menopausal hormone therapy may boost beneficial bacteria in vaginal microbial community

15 Sep 2024

Laughter yoga, acupressure, mindfulness program help relieve menopause symptoms

14 Sep 2024

Postmenopausal women may benefit from laughter yoga, acupressure, and a mindfulness-based stress reduction program, all of which have been shown to alleviated menopause symptoms and improve quality of life in a study.

Laughter yoga, acupressure, mindfulness program help relieve menopause symptoms

14 Sep 2024

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

14 Sep 2024 by

The novel oral corticotropin-releasing factor type 1 receptor antagonist crinecerfont helps supress androstenedione levels in children with congenital adrenal hyperplasia (CAH) and reduce the need for glucocorticoids, as shown in the phase III CAHtalyst Pediatric trial.

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

14 Sep 2024

Diabetes, insulin use up risk of death, cardiac events in AF patients

14 Sep 2024 by

In patients with atrial fibrillation (AF), being diabetic contributes to an increased risk of all-cause death, cardiovascular disease (CVD), myocardial infarction (MI), major bleeding, and major adverse cardiovascular events (MACE), results of the GLORIA-AF study have shown.

Diabetes, insulin use up risk of death, cardiac events in AF patients

14 Sep 2024

Bedtime screen use harms sleep in youths

14 Sep 2024

Using screens once already in bed appears to have a negative impact on sleep in young people, especially when screen time involves gaming or multitasking, according to a study.

Bedtime screen use harms sleep in youths

14 Sep 2024

GLP-1 receptor agonist use poses no risk of suicidality, self-harm

13 Sep 2024

Users of glucagon-like peptide-1 (GLP-1) receptor agonists, most of whom have type 2 diabetes, are not at increased risk of suicide death, self-harm, or incident depression and anxiety-related disorders, as shown in a study.

GLP-1 receptor agonist use poses no risk of suicidality, self-harm

13 Sep 2024

Tubal sterilization fails often enough, study says

13 Sep 2024 by

New research finds nontrivial rates of unintended pregnancy after tubal sterilization, which challenge the assumption that the procedure is a completely reliable form of birth control.

Tubal sterilization fails often enough, study says

13 Sep 2024

$Anti-TNFα agents safe, effective in steroid-refractory microscopic colitis$

Anti-TNFα agents safe, effective in steroid-refractory microscopic colitis

13 Sep 2024

Treatment with vedolizumab and antitumour necrosis factor-α agents provides clinical benefits, with an acceptable safety profile, in patients with steroid-refractory microscopic colitis (MC), suggests a study.

Anti-TNFα agents safe, effective in steroid-refractory microscopic colitis

13 Sep 2024

News & Updates

Filter by Specialty:

Specialty:

Enzalutamide edges out abiraterone in mCRPC

Enzalutamide edges out abiraterone in mCRPC

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney

NOACs better than VKAs at preventing deaths, CVD in AF patients with or without impaired kidney

Menopausal hormone therapy may boost beneficial bacteria in vaginal microbial community

Menopausal hormone therapy may boost beneficial bacteria in vaginal microbial community

Laughter yoga, acupressure, mindfulness program help relieve menopause symptoms

Laughter yoga, acupressure, mindfulness program help relieve menopause symptoms

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

Diabetes, insulin use up risk of death, cardiac events in AF patients

Diabetes, insulin use up risk of death, cardiac events in AF patients

Bedtime screen use harms sleep in youths

Bedtime screen use harms sleep in youths

GLP-1 receptor agonist use poses no risk of suicidality, self-harm

GLP-1 receptor agonist use poses no risk of suicidality, self-harm

Tubal sterilization fails often enough, study says

Tubal sterilization fails often enough, study says

Anti-TNFα agents safe, effective in steroid-refractory microscopic colitis

Anti-TNFα agents safe, effective in steroid-refractory microscopic colitis